General MedicationsINJECTIONGeneric
CEFMAX
CEFMENOXIME HYDROCHLORIDE
Standard Dose
EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CEFMAX is listed in Drugs@FDA under application 050571 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFMENOXIME HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor TAP PHARM Submission history Latest submission status date: 1988-05-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFMAX is listed in Drugs@FDA under application 050571 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFMENOXIME HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor TAP PHARM Submission history Latest submission status date: 1988-05-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.